Form 4: Myriad Genetics Executive Acquires Shares Through Performance-Based Stock Units

Dale Muzzey, Chief Scientific Officer of Myriad Genetics, acquired 10,622 shares of common stock on February 7, 2025, through the vesting of performance-based restricted stock units.

Summary

• On February 7, 2025, Dale Muzzey, the Chief Scientific Officer of Myriad Genetics, acquired 10,622 shares of the company's common stock.
• This acquisition was a result of the vesting of performance-based restricted stock units (PSUs) that were initially granted on March 22, 2022.
• The final award amount was determined by the Compensation and Human Capital Committee of the Board of Directors based on the achievement of pre-determined performance metrics.
• Each PSU represents a contingent right to receive one share of Myriad Genetics' common stock and vests on March 22, 2025.
• Following the transaction, Muzzey directly owns 117,766 shares of Myriad Genetics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of an insider transaction related to performance-based compensation. The vesting of PSUs suggests the company met certain performance goals, which is mildly positive.

Positives

• The vesting of performance-based restricted stock units suggests that the company has met certain pre-determined performance metrics, which is a positive indicator.
• The acquisition increases the executive's stake in the company, aligning their interests with those of shareholders.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their alignment with shareholder interests.

Comparison to Industry Standards

• Performance-based equity compensation is a common practice among publicly traded companies, particularly in the biotechnology and pharmaceutical industries.
• Companies like Illumina, Thermo Fisher Scientific, and Agilent Technologies also utilize similar compensation structures to incentivize executives and align their interests with long-term shareholder value.
• The specific performance metrics used to determine the vesting of PSUs vary from company to company, but often include financial targets, strategic milestones, and operational goals.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates that the executive's interests are aligned with those of the shareholders.

Key Dates